InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Coffin Robert, Président et Responsable R&D. Insider active across 1 company, notably Replimune Group, Inc.. Aggregated, 7 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €1m. History available since 28 June 2021. The latest transaction was filed on 16 May 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Coffin Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,464 shares@ US$6.473.8% of flowCommon StockSEC:0001104659-24-063560:0
7,861 shares@ US$18.057.3% of flowCommon StockSEC:0001104659-23-062377:0
45,000 shares0Common StockSEC:0001104659-23-041718:0
5,737 shares@ US$14.597.7% of flowCommon StockSEC:0001104659-22-062606:0
26,250 shares0Common StockSEC:0001104659-22-042771:0
7,810 shares@ US$40.0425.5% of flowCommon StockSEC:0001104659-21-089919:0
14,663 shares@ US$40.0447.5% of flowCommon StockSEC:0001104659-21-087803:0
7 of 7 declarations
About Coffin Robert
Robert Coffin is President & Chief R&D Officer at Replimune Group, Inc. He is responsible for leading the company's research and development efforts. His role is essential in guiding innovation initiatives and product development.
